p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.

We have identified clusters of specific molecular alterations that greatly improve prognostic assessment with respect to singularly-analysed indicators. The combined analysis of these multiple tumor-relapse risk factors promises to become a powerful approach to identify patients subgroups with unfavourable disease outcome.